Hbk Sorce Advisory LLC Regeneron Pharmaceuticals, Inc. Transaction History

Hbk Sorce Advisory LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$883.2 - $1071.19 $171,340 - $207,810	194 New	194 $203,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $161,956 - $196,818	238 New	238 $298,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $357,830 - $439,108	-801 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $64,570 - $82,077	-135 Reduced 14.42%	801 $387,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $110,039 - $132,958	-202 Reduced 17.75%	936 $524,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $561,398 - $732,780	1,138 New	1,138 $710,000
Q4 2017 Feb 15, 2018	SELL	$358.63 - $469.95 $161,742 - $211,947	-451 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $194,552 - $227,304	451	451 $202,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.